Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Traxler

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmacology & Therapeutics|August 24, 1999
Strategies toward the design of novel and selective protein tyrosine kinase inhibitorsP Traxler, P Furet
The Journal of Antibiotics|August 1, 1987
Papulacandins--synthesis and biological activity of papulacandin B derivativesP Traxler, W Tosch, O Zak
The Journal of Antibiotics|November 1, 1978
Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin IO Ghisalba, P Traxler, J Nüesch
The Journal of Antibiotics|November 1, 1983
Papulacandins--the relationship between chemical structure and effect on glucan synthesis in yeastG Römmele, P Traxler, W Wehrli
The Journal of Antibiotics|August 1, 1981
New rifamycins produced by a recombinant strain of Nocardia mediterraneiT Schupp, P Traxler, J A Auden
The Journal of Antibiotics|April 1, 1977
Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and EP Traxler, J Gruner, J A Auden
Journal of Medicinal Chemistry|February 1, 1990
Hypolipidemic activity of rifamycin derivativesP Traxler, W Kump, K Mueller, et al.
EXS|September 21, 2000
Molecular approaches to receptors as targets for drug discoveryD B Evans, P Traxler, C García-Echeverría
Medicinal Research Reviews|December 23, 1999
ATP site-directed competitive and irreversible inhibitors of protein kinasesC García-Echeverría, P Traxler, D B Evans
The Journal of Antibiotics|August 1, 1981
3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterraneiP Traxler, T Schupp, H Fuhrer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacology & Therapeutics|August 24, 1999
Strategies toward the design of novel and selective protein tyrosine kinase inhibitorsP Traxler, P Furet
The Journal of Antibiotics|August 1, 1987
Papulacandins--synthesis and biological activity of papulacandin B derivativesP Traxler, W Tosch, O Zak
The Journal of Antibiotics|November 1, 1978
Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin IO Ghisalba, P Traxler, J Nüesch
The Journal of Antibiotics|November 1, 1983
Papulacandins--the relationship between chemical structure and effect on glucan synthesis in yeastG Römmele, P Traxler, W Wehrli
The Journal of Antibiotics|August 1, 1981
New rifamycins produced by a recombinant strain of Nocardia mediterraneiT Schupp, P Traxler, J A Auden
The Journal of Antibiotics|April 1, 1977
Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and EP Traxler, J Gruner, J A Auden
Journal of Medicinal Chemistry|February 1, 1990
Hypolipidemic activity of rifamycin derivativesP Traxler, W Kump, K Mueller, et al.
EXS|September 21, 2000
Molecular approaches to receptors as targets for drug discoveryD B Evans, P Traxler, C García-Echeverría
Medicinal Research Reviews|December 23, 1999
ATP site-directed competitive and irreversible inhibitors of protein kinasesC García-Echeverría, P Traxler, D B Evans
The Journal of Antibiotics|August 1, 1981
3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterraneiP Traxler, T Schupp, H Fuhrer, et al.
Pageof 3